{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T12:48:54Z","timestamp":1762865334375,"version":"build-2065373602"},"reference-count":43,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T00:00:00Z","timestamp":1428624000000},"content-version":"vor","delay-in-days":2687,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1016\/j.bbmt.2007.09.007","type":"journal-article","created":{"date-parts":[[2007,11,26]],"date-time":"2007-11-26T17:09:44Z","timestamp":1196096984000},"page":"1515-1524","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["CD3+ Cell Dose and Disease Status Are Important Factors Determining Clinical Outcomes in Patients Undergoing Unmanipulated Haploidentical Blood and Marrow Transplantation after Conditioning Including Antithymocyte Globulin"],"prefix":"10.1016","volume":"13","author":[{"given":"Lujia","family":"Dong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei-Jie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-Yong","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dao-Pei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2007.09.007_bib1","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1136\/bmj.2.4993.626","article-title":"Treatment of murine leukemia with x-rays and homologous bone marrow: preliminary communication","volume":"2","author":"Barnes","year":"1956","journal-title":"BMJ"},{"key":"10.1016\/j.bbmt.2007.09.007_bib2","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/BF02982034","article-title":"Hematopoietic cell transplantation as a form of immunotherapy","volume":"75","author":"Appelbaum","year":"2002","journal-title":"Int J Hematol"},{"key":"10.1016\/j.bbmt.2007.09.007_bib3","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1001\/jama.1983.03330330044034","article-title":"Bone marrow transplantation for acute myelogenous leukemia","volume":"249","author":"Bortin","year":"1983","journal-title":"JAMA"},{"key":"10.1016\/j.bbmt.2007.09.007_bib4","doi-asserted-by":"crossref","first-page":"3930","DOI":"10.1182\/blood-2002-01-0339","article-title":"Transplant-related mortality and long-term graft function are significantly influenced by cell dose in patients undergoing allogeneic marrow transplantation","volume":"100","author":"Dominietto","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.09.007_bib5","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1182\/blood.V97.2.383","article-title":"The number of donor CD3+ cells is the most important factor for graft failure after allogeneic transplantation of CD34+ selected cells from peripheral blood from HLA-identical siblings","volume":"97","author":"Urbano-Ispizua","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.09.007_bib6","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.exphem.2004.07.020","article-title":"CD8+ T-cell dose affects development of acute graft-versus-host disease following reduced-intensity conditioning allogeneic peripheral blood stem cell transplantation","volume":"32","author":"Mohty","year":"2004","journal-title":"Exp Hematol"},{"key":"10.1016\/j.bbmt.2007.09.007_bib7","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1089\/hum.1994.5.12-1523","article-title":"Study on contribution of genetically marked peripheral blood repopulating cells to hematopoietic reconstitution after transplantation","volume":"5","author":"Schuening","year":"1994","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.bbmt.2007.09.007_bib8","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1200\/JCO.2000.18.6.1360","article-title":"Therapeutic relevance of CD34 cell dose in blood cell transplantation for cancer therapy","volume":"18","author":"Siena","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2007.09.007_bib9","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/00062752-199704060-00010","article-title":"Use of stem cells from mismatched related donors","volume":"4","author":"Aversa","year":"1997","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.bbmt.2007.09.007_bib10","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.exphem.2004.12.004","article-title":"CD34, CD4, and CD8 cell doses do not influence engraftment, graft-versus-host disease, or survival following myeloablative human leukocyte antigen-identical peripheral blood allografting for hematologic malignancies","volume":"33","author":"Cao","year":"2005","journal-title":"Exp Hematol"},{"key":"10.1016\/j.bbmt.2007.09.007_bib11","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1749-6632.1999.tb08479.x","article-title":"Transplantation of megadoses of purified haploidentical stem cells","volume":"872","author":"Handgretinger","year":"1999","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.bbmt.2007.09.007_bib12","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.bcmd.2004.08.016","article-title":"Graft engineering for allogeneic haploidentical stem cell transplantation","volume":"33","author":"Tabilio","year":"2004","journal-title":"Blood Cells Mol Dis"},{"issue":"8","key":"10.1016\/j.bbmt.2007.09.007_bib13","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1182\/blood-2005-05-2146","article-title":"Conditioning including antithymocyte globulin followed by un-manipulated HLA-mismatched\/haploidentical blood and marrow transplantation can achieve comparable outcomes to HLA-identical sibling transplantation","volume":"107","author":"Lu","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.09.007_bib14","doi-asserted-by":"crossref","first-page":"419","DOI":"10.3109\/10428199509054428","article-title":"Expression of MDR by normal bone marrow cells and its implication for leukemia hematopoiesis","volume":"16","author":"Drach","year":"1995","journal-title":"Leukemia Lymphoma"},{"key":"10.1016\/j.bbmt.2007.09.007_bib15","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1056\/NEJM197504172921605","article-title":"Bone marrow transplantation","volume":"292","author":"Thomas","year":"1975","journal-title":"New Engl J Med"},{"key":"10.1016\/j.bbmt.2007.09.007_bib16","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1182\/blood.V71.2.293.293","article-title":"Cyclosporine versus methotrexate for graft-versus-host disease prevention in patients given marrow grafts for leukemia: long-term follow-up of three controlled trials","volume":"71","author":"Storb","year":"1988","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.09.007_bib17","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/00007890-197410000-00001","article-title":"Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors","volume":"18","author":"Glucksberg","year":"1974","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2007.09.007_bib18","first-page":"250","article-title":"Chronic graft-versus-host disease and other late complications of bone marrow transplantation","volume":"28","author":"Sullivan","year":"1991","journal-title":"Semin Hematol"},{"key":"10.1016\/j.bbmt.2007.09.007_bib19","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/0002-9343(80)90380-0","article-title":"Chronic graft-versus-host syndrome in man: a long-term clinicopathologic study of 20 Seattle patients","volume":"69","author":"Shulman","year":"1980","journal-title":"Am J Med"},{"key":"10.1016\/j.bbmt.2007.09.007_bib20","doi-asserted-by":"crossref","first-page":"3821","DOI":"10.1182\/blood-2004-03-1212","article-title":"Feasibility of HLA-haploidentical hematopoietic stem cell transplantation between noninherited maternal antigen (NIMA)-mismatched family members linked with long-term fetomaternal microchimerism","volume":"104","author":"Ichinohe","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.09.007_bib21","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1016\/S0198-8859(00)00211-1","article-title":"Noninherited maternal HLA antigens: a proposal to elucidate their role in the immune response","volume":"61","author":"Van Rood","year":"2000","journal-title":"Hum Immunol"},{"key":"10.1016\/j.bbmt.2007.09.007_bib22","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/sj.bmt.1705464","article-title":"Alternative donor transplants for adult acute lymphoblastic leukaemia: a comparison of the three major options","volume":"38","author":"Marks","year":"2006","journal-title":"Bone Marrow Transplant"},{"issue":"Suppl 1","key":"10.1016\/j.bbmt.2007.09.007_bib23","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/BF03165238","article-title":"Haploidentical stem cell transplantation for acute leukemia","volume":"76","author":"Aversa","year":"2002","journal-title":"Int J Hematol"},{"key":"10.1016\/j.bbmt.2007.09.007_bib24","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1182\/blood-2006-07-038687","article-title":"Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value","volume":"110","author":"Ruggeri","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.09.007_bib25","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1365-2141.2006.06140.x","article-title":"Haploidentical stem cell transplantation for children with acute leukaemia","volume":"134","author":"Marks","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2007.09.007_bib26","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1182\/blood-2006-02-001909","article-title":"Adoptive immunotherapy with allodepleted donor T-cells improves immune reconstitution after haploidentical stem cell transplantation","volume":"108","author":"Amrolia","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.09.007_bib27","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/01.tp.0000251975.81281.22","article-title":"Antithymocyte globulins suppress dendritic cell function by multiple mechanisms","volume":"83","author":"Naujokat","year":"2007","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2007.09.007_bib28","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1097\/01.mph.0000184575.00717.25","article-title":"Antithymocyte globulin pharmacokinetics in pediatric patients after hematopoietic stem cell transplantation","volume":"27","author":"Seidel","year":"2005","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.bbmt.2007.09.007_bib29","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/S1083-8791(03)00127-7","article-title":"Pharmacokinetics and pharmacodynamics of anti-thymocyte globulin in recipients of partially HLA-matched blood hematopoietic progenitor cell transplantation","volume":"9","author":"Waller","year":"2003","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2007.09.007_bib30","first-page":"869B","article-title":"Rabbit-immunoglobulin G levels in patients receiving thymoglobulin as part of conditioning before unrelated donor stem cell transplantation","volume":"90","author":"Remberger","year":"2005","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2007.09.007_bib31","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S1083-8791(00)70035-8","article-title":"Comparison of granulocyte colony-stimulating factor (G-CSF)\u2013mobilized peripheral blood progenitor cells and G-CSF\u2013stimulated bone marrow as a source of stem cells in HLA-matched sibling transplantation","volume":"6","author":"Serody","year":"2000","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2007.09.007_bib32","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/sj.bmt.1703769","article-title":"G-CSF\u2013primed haploidentical marrow transplantation without ex vivo T cell depletion: an excellent alternative for high-risk leukemia","volume":"30","author":"Ji","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2007.09.007_bib33","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.trim.2006.10.002","article-title":"Maintaining hyporesponsiveness and polarization potential of T cells after in vitro mixture of G-CSF\u2013mobilized peripheral blood grafts and G-CSF\u2013primed bone marrow grafts in different proportions","volume":"17","author":"Huang","year":"2007","journal-title":"Transplant Immunol"},{"key":"10.1016\/j.bbmt.2007.09.007_bib34","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1038\/sj.leu.2404777","article-title":"Transplantation of mesenchymal stem cells to enhance engraftment of hematopoietic stem cells","volume":"21","author":"Le Blanc","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2007.09.007_bib35","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1080\/14653240601045399","article-title":"Mesenchymal stromal cells: tissue repair and immune modulation","volume":"8","author":"Le Blanc","year":"2006","journal-title":"Cytotherapy"},{"key":"10.1016\/j.bbmt.2007.09.007_bib36","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1097\/01.tp.0000214462.63943.14","article-title":"Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease","volume":"81","author":"Ringd\u00e9n","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2007.09.007_bib37","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.bbmt.2005.02.001","article-title":"Co-transplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients","volume":"11","author":"Lazarus","year":"2005","journal-title":"Biology Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2007.09.007_bib38","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1182\/blood-2004-04-1559","article-title":"Human mesenchymal stem cells modulate allogeneic immune cell responses","volume":"105","author":"Aggarwal","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.09.007_bib39","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1532\/IJH97.A30409","article-title":"Co-transplantation of marrow stromal cells may prevent lethal graft-versus-host disease in major histocompatibility complex mismatched murine hematopoietic stem cell transplantation","volume":"80","author":"Chung","year":"2004","journal-title":"Int J Hematol"},{"issue":"6","key":"10.1016\/j.bbmt.2007.09.007_bib40","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1182\/blood-2007-04-083162","article-title":"Human multipotent mesenchymal stromal cells inhibit proliferation of PBMCs independently of IFN\u03b3R1-signaling and IDO expression","volume":"110","author":"Gieseke","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.09.007_bib41","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/sj.bmt.1701029","article-title":"A pilot study of allogeneic bone marrow transplantation using related donor stimulated with G-CSF","volume":"20","author":"Isola","year":"1997","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2007.09.007_bib42","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S1083-8791(00)70033-4","article-title":"Bone marrow mobilized with granulocyte colony-stimulating factor in related allogeneic transplant recipients: a study of 29 patients","volume":"6","author":"Couban","year":"2000","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2007.09.007_bib43","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1182\/blood-2006-07-034348","article-title":"Hyperacute GVHD: risk factors, outcomes, and clinical implications","volume":"109","author":"Saliba","year":"2007","journal-title":"Blood"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879107004557?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879107004557?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:30:13Z","timestamp":1761057013000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879107004557"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":43,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["S1083879107004557"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2007.09.007","relation":{},"ISSN":["1083-8791"],"issn-type":[{"type":"print","value":"1083-8791"}],"subject":[],"published":{"date-parts":[[2007,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CD3+ Cell Dose and Disease Status Are Important Factors Determining Clinical Outcomes in Patients Undergoing Unmanipulated Haploidentical Blood and Marrow Transplantation after Conditioning Including Antithymocyte Globulin","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2007.09.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}